Cargando…

Lung Transplantation and the Era of the Sensitized Patient

Long term outcomes in lung transplant are limited by the development of chronic lung allograft dysfunction (CLAD). Within the past several decades, antibody-mediated rejection (AMR) has been recognized as a risk factor for CLAD. The presence of HLA antibodies in lung transplant candidates, “sensitiz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Young, Katherine A., Ali, Hakim A., Beermann, Kristi J., Reynolds, John M., Snyder, Laurie D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187850/ https://www.ncbi.nlm.nih.gov/pubmed/34122454 http://dx.doi.org/10.3389/fimmu.2021.689420

Ejemplares similares

Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation
por: Morath, Christian, et al.
Publicado: (2020)

Editorial: Liver transplantation for liver cancer in the era of transplant oncology: accurate diagnosis and treatment
por: Xiang, Ze, et al.
Publicado: (2023)

Allogeneic hematopoietic stem cell transplantation in the COVID-19 era
por: Bordat, Jonathan, et al.
Publicado: (2023)

Editorial: Sensitization and Desensitization in Organ Transplantation
por: Anwar, Imran J., et al.
Publicado: (2021)

Airway Telomere Length in Lung Transplant Recipients
por: Mackintosh, John A., et al.
Publicado: (2021)

Transplanting Marginal Organs in the Era of Modern Machine Perfusion and Advanced Organ Monitoring
por: Resch, Thomas, et al.
Publicado: (2020)

Into the multi-omics era: Progress of T cells profiling in the context of solid organ transplantation
por: Zhi, Yao, et al.
Publicado: (2023)

Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era
por: Li, Huanhuan, et al.
Publicado: (2023)

Evaluating Thymic Function After Human Hematopoietic Stem Cell Transplantation in the Personalized Medicine Era
por: Gaballa, Ahmed, et al.
Publicado: (2020)

Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres
por: Trindade, Anil J., et al.
Publicado: (2020)

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
por: Furukawa, Masashi, et al.
Publicado: (2022)

Antibodies against Apoptotic Cells Present in End-stage Lung Disease Patients Do Not Correlate with Clinical Outcome after Lung Transplantation
por: Budding, Kevin, et al.
Publicado: (2017)

Case Report: An Unusual Course of Angiosarcoma After Lung Transplantation
por: Bos, Saskia, et al.
Publicado: (2022)

Intragraft Hyaluronan Increases in Association With Acute Lung Transplant Rejection
por: Hostetler, Haley P., et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells in Lung Transplantation
por: Heigl, Tobias, et al.
Publicado: (2019)

Revisiting the Principles of Preservation in an Era of Pandemic Obesity
por: Langford, John T., et al.
Publicado: (2022)

Cryoablation and immunity in non-small cell lung cancer: a new era of cryo-immunotherapy
por: Velez, Antonio, et al.
Publicado: (2023)

Navigate Towards the Immunotherapy Era: Value of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Brain Metastases
por: Yang, Guanqun, et al.
Publicado: (2022)

The UK kidney donor risk index poorly predicts long-term transplant survival in paediatric kidney transplant recipients
por: Kim, Jon Jin, et al.
Publicado: (2023)

Xenotransplantation: A New Era
por: Carrier, Amber N., et al.
Publicado: (2022)

Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation
por: Nayak, Deepak Kumar, et al.
Publicado: (2016)

Novel approaches for long-term lung transplant survival
por: Miller, Cynthia L., et al.
Publicado: (2022)

A Single Nucleotide C3 Polymorphism Associates With Clinical Outcome After Lung Transplantation
por: Kardol-Hoefnagel, Tineke, et al.
Publicado: (2019)

Reduced Expression of Membrane Complement Regulatory Protein CD59 on Leukocytes following Lung Transplantation
por: Michielsen, Laura A., et al.
Publicado: (2018)

Editorial: T-Cell and Antibody-Mediated Rejection After Organ Transplantation in the Post-COVID-19 Era – Diagnosis, Immunological Risk Evaluation and Therapy
por: Slavcev, Antonij, et al.
Publicado: (2022)

Association between a Single Donor TARC/CCL17 Promotor Polymorphism and Obstructive Chronic Lung Allograft Dysfunction after Lung Transplantation
por: Budding, Kevin, et al.
Publicado: (2017)

Differential Sensitivity of Regulatory and Effector T Cells to Cell Death: A Prerequisite for Transplant Tolerance
por: You, Sylvaine
Publicado: (2015)

Real-world landscape transition of death causes in the immunotherapy era for metastatic non-small cell lung cancer
por: Wu, Yijun, et al.
Publicado: (2022)

Allogeneic Hematopoietic Stem Cell Transplantation After Prior Lung Transplantation for Hereditary Pulmonary Alveolar Proteinosis: A Case Report
por: Beeckmans, Hanne, et al.
Publicado: (2022)

Set Up for Failure: Pre-Existing Autoantibodies in Lung Transplant
por: McQuiston, Alexander, et al.
Publicado: (2021)

Monitoring regulatory T cells as a prognostic marker in lung transplantation
por: Khan, Mohammad Afzal, et al.
Publicado: (2023)

Epstein-Barr Virus Reactivation After Paediatric Haematopoietic Stem Cell Transplantation: Risk Factors and Sensitivity Analysis of Mathematical Model
por: Kania, Soumya P., et al.
Publicado: (2022)

Role of FK506-sensitive signals in asthmatic lung inflammation
por: Tomiaki, Chihiro, et al.
Publicado: (2022)

Erratum: Real-world landscape transition of death causes in the immunotherapy era for metastatic non-small cell lung cancer
Publicado: (2022)

Modeling Human Natural Killer Cell Development in the Era of Innate Lymphoid Cells
por: Scoville, Steven D., et al.
Publicado: (2017)

The challenge of making the right choice: patient avatars in the era of cancer immunotherapies
por: Kayser, Charlotte, et al.
Publicado: (2023)

The Autoimmune-Associated Single Nucleotide Polymorphism Within PTPN22 Correlates With Clinical Outcome After Lung Transplantation
por: Budding, Kevin, et al.
Publicado: (2019)

Positron Emission Tomography to Improve Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation
por: Broens, Bo, et al.
Publicado: (2022)

Prognosis of hyperviscosity syndrome in newly diagnosed multiple myeloma in modern-era therapy: A real-life study
por: Debureaux, Pierre-Edouard, et al.
Publicado: (2022)

The Era of Cytotoxic CD4 T Cells
por: Cenerenti, Mara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p7fcjiaiv1e2585indtii041or